Brian Morris | Hypertension | Best Academic Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Brian Morris | Hypertension | Best Academic Researcher Award

University Of Sydney | Australia

Professor Dr. Brian Morris is a highly respected biomedical scientist and Professor Emeritus at the School of Medical Sciences, University of Sydney, acclaimed for his groundbreaking research in molecular medical sciences, hypertension, and public health. Throughout his distinguished career, he has made substantial contributions to understanding the genetic and molecular foundations of cardiovascular disease and ageing. He has held several prominent academic positions, including Professor of Molecular Medical Sciences and Senior Lecturer in Physiology, and has provided influential leadership in organizing international scientific conferences, such as the first global meeting on the molecular genetics of hypertension. Professor Morris has also served on major national and international research committees, editorial boards, and review panels, and is recognized as an exceptional mentor whose students have gone on to achieve senior positions in academia and industry worldwide. His numerous honors and fellowships from prestigious organizations reflect his exceptional contributions to science and education. With a prolific publication record of 404 documents, his research has received 11,835 citations from 8,579 documents, achieving an h-index of 56. His studies, published in leading journals including Circulation, Nature Genetics, PNAS, and Hypertension, have influenced scientific thought globally. His pioneering patent for the first use of PCR in viral detection further underscores his lasting impact on molecular diagnostics. Through his scientific innovation, academic leadership, and lifelong dedication to advancing knowledge, Professor Morris has made enduring contributions to cardiovascular and molecular health research worldwide.

Profiles: Scopus | Orcid

Featured Publications

Sarman, G., Cox, G., & Morris, B. J. (2025). Critique of “The impact of foot reflexology on postoperative pain and fear in children following circumcision: A randomized controlled trial.” Journal of Pediatric Urology.

Cox, G., & Morris, B. J. (2025). Comments on Fendereski et al., Comparing penile problems in circumcised vs. uncircumcised boys: Insights from a large commercial claims database with a focus on provider type performing circumcision. Journal of Pediatric Surgery.

Chen, R., Donlon, T. A., Morris, B. J., Allsopp, R. C., Willcox, B. J., & Masaki, K. H. (2024). Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer.

Chen, R., Morris, B. J., Donlon, T. A., Nakagawa, K., Allsopp, R. C., Willcox, B. J., Masaki, K. H., & Lipsitz, L. A. (2024). FOXO3 longevity genotype mitigates risk posed by hypertension on incident coronary artery disease in middle-aged men: Kuakini Honolulu Heart Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Morris, B. J., & Banerjee, J. (2024). Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’. Journal of Biosocial Science.

Morris, B. J., & Klausner, J. D. (2024). Detrimental to public health: Royal Australasian College of Physicians’ recent policy on infant circumcision. Pediatric Research.

Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Shenzhen University | China

Mr. Ibtasam Wajid is an emerging researcher whose work focuses on the intersection of biomedical engineering, health informatics, and data science, with a particular interest in developing innovative machine learning and deep learning models for improving healthcare outcomes. His research explores how advanced computational techniques can be applied to disease prediction, medical imaging, and clinical decision support, contributing to the growing field of digital health transformation. With an academic background spanning biochemistry, health informatics, and biomedical research, he brings an interdisciplinary perspective to addressing complex challenges in modern medicine. He has authored three research documents, accumulating a total of six citations and holding an h-index of one, reflecting a steadily growing research impact at an early stage of his academic career. Alongside his research contributions, he has actively participated in mentoring undergraduate students, organizing technical workshops, and promoting collaborative learning environments within the scientific community. His ongoing studies and projects continue to focus on integrating artificial intelligence into healthcare systems to enhance accuracy, efficiency, and patient-centered care. Through his dedication to continuous learning and innovation, he demonstrates the potential to make lasting contributions to biomedical science and the advancement of data-driven healthcare solutions worldwide.

Profiles: Scopus | Google Scholar

Featured Publications

Sultan, H., Javed, I., Zubair, M., Iqbal, K., Bilal, M., Iqbal, J., & Wajid, I. (2021). Protein and polysaccharide-based biomaterial for the formation of composite bone scaffold. AlQalam Journal of Medical and Applied Sciences, 4(2), 80–88.

Wajid, I., Dan, L., & Wang, Q. (2025). Hybrid ensemble approaches for cardiovascular disease prediction: Leveraging interpretable AI for clinical insight. Intelligence-Based Medicine, 100297.

Ishaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.

Jian Wang | Vascular regeneration | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Jian Wang | Vascular regeneration | Best Researcher Award

Yunnan University of Chinese Medicine | China

Author Profile:

Scopus

🌟 JIAN WANG: PIONEER IN TRADITIONAL CHINESE MEDICINE FOR NEUROLOGICAL HEALTH

🎓 EARLY ACADEMIC PURSUITS

Jian Wang embarked on his academic journey with a profound interest in the integration of Traditional Chinese Medicine (TCM) and modern neurological science. From the outset of his career, he demonstrated exceptional dedication to understanding the molecular and clinical pathways underlying neurological disorders. His educational background, though not explicitly detailed, reflects extensive scholarly preparation, equipping him to contribute significantly to both basic and clinical research in the realm of stroke and cerebral ischemia.

🧑‍⚕️ PROFESSIONAL ENDEAVORS

Jian Wang serves as a Discipline Leader and Technological Innovation Talent of Yunnan Province and is recognized as a Senior Talent in Traditional Chinese Medicine of Yunnan Province. He is currently affiliated with Yunnan University of Chinese Medicine, where he actively leads research teams, mentors young scientists, and advances the field of integrative neurology. His leadership roles underscore his commitment to elevating the scientific standing of Traditional Chinese Medicine both regionally and nationally.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON VASCULAR REGENERATION

Professor Wang's research is rooted in neuroprotection, stroke therapy, and inflammatory response modulation, using both experimental models and clinical applications of TCM. His focus spans:

  • Cuproptosis mechanisms in stroke pathogenesis 🧪

  • Electroacupuncture's effects on inflammation and neural regeneration ⚡

  • Network pharmacology and molecular docking for TCM compounds 🌿

  • Gut microbiota's role in osteoarthritis and brain health 🦠

  • Innovative TCM formulations for cognitive impairment and nephritis 🧠

Through these endeavors, he bridges modern biomedical science with classical Chinese therapeutics, enhancing treatment modalities for cerebral ischemia, stroke, and neuroinflammatory disorders.

📚 ACADEMIC CITES AND PUBLICATIONS

Jian Wang has co-authored numerous high-impact publications in esteemed journals such as Frontiers in Molecular Neuroscience, Neuroreport, and the American Journal of Chinese Medicine. Key articles include:

  • Studies on cuproptosis in stroke (Front Mol Neurosci, 2024)

  • Mechanistic insights on electroacupuncture (Neuroreport, 2025)

  • Gut microbiota links to osteoarthritis (Am J Chin Med, 2025)

  • TCM compound analyses using network pharmacology (Chem Biodivers, 2025)

These publications reflect his role as a thought leader in the evolving dialogue between Eastern and Western medical sciences.

🔍 RESEARCH PROJECTS AND SCIENTIFIC LEADERSHIP

Jian Wang has been entrusted with several prestigious research grants, including:

  • National Natural Science Foundation of China (NSFC) projects exploring electroacupuncture's role in nerve regeneration.

  • Yunnan Provincial Science and Technology Department initiatives focusing on inflammatory pathways such as NF-κB, NLRP3, and NAMPT in stroke models.

As a Principal Investigator, his projects not only advance basic science but also hold direct clinical implications for stroke rehabilitation and neurological recovery.

🌏 IMPACT AND INFLUENCE

Beyond his individual research achievements, Jian Wang plays a pivotal role in mentoring emerging researchers in Traditional Chinese Medicine. His work influences clinical practices in Yunnan Province and contributes to international scientific dialogues on stroke management, neuroinflammation, and integrative medicine.

His studies on electroacupuncture, paeony glucosides, and Ligusticum wallichii-Borneol combinations are referenced by scholars exploring alternative therapeutic strategies for stroke, vasculitis nephritis, and neurodegeneration.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Jian Wang's enduring legacy lies in his pioneering integration of TCM and neuroscience, setting a standard for multidisciplinary approaches to brain health. Looking ahead, his ongoing projects aim to further elucidate:

  • The regenerative pathways triggered by TCM therapies,

  • Novel targets for post-stroke neurorehabilitation,

  • Expanded clinical trials validating acupuncture and herbal treatments for neurological diseases.

His vision encompasses making Traditional Chinese Medicine a globally recognized and scientifically validated option for treating complex neurological conditions.

📑NOTABLE PUBLICATIONS

"Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities"

Authors: Xi Y, Wang Z, Wei Y, Xiao N, Duan L, Zhao T, Zhang X, Zhang L, Wang J, Li Z, Qin D
Journal: American Journal of Chinese Medicine
Year: 2025

"Cuproptosis in stroke: focusing on pathogenesis and treatment"

Authors: Xing L, Wang Z, Hao Z, Pan P, Yang A, Wang J
Journal: Frontiers in Molecular Neuroscience
Year: 2024

 

Cheng Shen | Cardiac Surgery | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Cheng Shen | Cardiac Surgery | Best Researcher Award

West China Hospital | China

Author Profile: 

Scopus

Orcid

📘 EARLY ACADEMIC PURSUITS 

Cheng Shen began his academic journey at Kunming Medical University, earning his Bachelor of Medicine in Clinical Medicine in 2011. His passion for clinical excellence and research led him to the West China School of Medicine, Sichuan University, where he pursued a Ph.D. in Thoracic Surgery while simultaneously working as a Resident Doctor and Research Assistant from 2011 to 2017. During this period, he honed his clinical and research acumen, laying a strong foundation for his future contributions to oncology and thoracic surgery.

🩺 PROFESSIONAL ENDEAVORS

Dr. Cheng Shen currently serves as an Attending Physician in the Department of Thoracic Surgery at West China Hospital, Sichuan University. His international academic exposure includes his time as a Visiting Scholar at Yale University (2015–2016) in the Department of Molecular Biophysics and Biochemistry, where he advanced his expertise in molecular mechanisms of DNA repair. This blend of clinical practice and laboratory precision has equipped him to lead cutting-edge investigations in thoracic oncology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC SURGERY

Dr. Shen’s research spans several high-impact domains, including:

  • Targeted Gene Therapy and Immunotherapy

  • Molecular Mechanisms of Cancer Invasion and Metastasis

  • Cell and Tissue Engineering

  • Stem Cell Function and Differentiation

His research during his Yale tenure focused on the mechanism of homology-directed DNA repair, using yeast and human models. He also explored genomic instability in primary lung cancers and conducted studies on cancer-associated fibroblasts in lung adenocarcinoma.

🌐 IMPACT AND INFLUENCE 

Cheng Shen has contributed significantly to the understanding of tumor biology, particularly in thoracic malignancies. His ability to translate complex molecular biology into practical clinical insights makes him a crucial figure in personalized cancer therapy. He has also designed and led several small clinical trials, emphasizing his commitment to bridging the bench-to-bedside gap.

🏅 ACADEMIC CITES AND COLLABORATIONS

While specific citation counts are not provided, his training at Yale University, multiple national-level scholarships, and leadership in clinical trials reflect a robust academic profile. His research work is likely referenced in the fields of genomic instability, lung cancer, and DNA repair mechanisms.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Cheng Shen’s future appears poised for further breakthroughs in thoracic cancer treatment and regenerative medicine. As a physician-scientist with deep laboratory roots and clinical experience, he is uniquely positioned to drive innovation in cancer therapy, particularly with emerging gene and cell-based interventions. His trajectory indicates continued leadership in integrative and translational medical research.

🏆 OTHER IMPORTANT AREAS OF EXCELLENCE 

LANGUAGE PROFICIENCY:

  • Advanced in English, having cleared PETS-3, PETS-4, CET-4, and CET-6.

LAB PROFICIENCY:

  • Expertise in PCR, Western Blot, ELISA, Cell Culture, and Signaling Pathway Inhibition.

  • Strong in Animal Models and Transwell Cell Migration assays.

HONORS & SCHOLARSHIPS:

  • State Scholarship Fund (CSC) (2015–2017)

  • National Graduate Scholarships (2012–2014)

  • Full Scholarship from Sichuan University (2011–2016)

  • Multiple Merit Scholarships during undergraduate studies

NOTABLE PUBLICATIONS

"Accuracy of Large Language Models for Literature Screening in Thoracic Surgery: Diagnostic Study"

Authors: ZY Dai, FQ Wang, C Shen, YL Ji, ZY Li, Y Wang, Q Pu
Journal: Journal of Medical Internet Research
Year: 2025

"A combined subsegmentectomy of right S9 + 10b with single direction thoracoscopic surgery"

Authors: C Shen, C Liu
Journal: Journal of Cardiothoracic Surgery
Year: 2024

"Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: A systematic review and meta-analysis"

Authors: Shen C, Li J, Li J, Che G
Journal: Thoracic Cancer
Year: 2022